The big question is how long will it take to find 10 bile duct cancer patients who have failed at least 2 prior lines of treatment across 10 sites in the US and a few here in Australia?
And we are about to present at the very niche cholangiocarcinoma conference in the US. Magnificent marketing opportunity and hopefully providing a glimmer of hope for 10 very fortunate souls. This could all move very quickly now. Perhaps one more dose escalation just to be certain. This is truely exceptional news.
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance, page-31
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.002(2.59%) |
Mkt cap ! $413.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.6¢ | $1.050M | 18.40M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1515419 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1023134 | 29 |
View Market Depth
| Last trade - 15.44pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.002 ( 0.89 %) |
||||
| Open | High | Low | Volume | ||
| 5.7¢ | 5.8¢ | 5.6¢ | 9460825 | ||
| Last updated 15.59pm 18/06/2024 ? | |||||
| IMU (ASX) Chart |